Location: London, United Kingdom
CIK: 0001131399 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $599M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR THERAPEUTICS AG | 3,220,627 | $153M | 25.6% | $59.89 | -10.7% | NAMEN AKT | H17182108 |
| WVE | WAVE LIFE SCIENCES LTD | 18,245,691 | $132M | 22.1% | $10.16 | +35.3% | SHS | Y95308105 |
| BNTX | BIONTECH SE | 889,824 | $79.09M | 13.2% | $95.20 | — | SPONSORED ADS | 09075V102 |
| VIR | VIR BIOTECHNOLOGY INC | 8,550,954 | $76.62M | 12.8% | $5.95 | +21.0% | COM | 92764N102 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,333,333 | $44.43M | 7.4% | $31.88 | +6.2% | COM | 45166A102 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,512,659 | $30.34M | 5.1% | $22.38 | +8.7% | COM NEW | 55083R203 |
| CYTK | CYTOKINETICS INC | 340,434 | $22.44M | 3.7% | $62.21 | +3.6% | COM NEW | 23282W605 |
| SPRO | SPERO THERAPEUTICS INC | 9,190,606 | $21.51M | 3.6% | $2.32 | +2.0% | COM | 84833T103 |
| FULC | FULCRUM THERAPEUTICS INC | 1,785,714 | $13.7M | 2.3% | $10.18 | +1.9% | COM | 359616109 |
| CVRX | CVRX INC | 1,007,583 | $9.532M | 1.6% | $9.13 | -27.0% | COM | 126638105 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,529,561 | $7.097M | 1.2% | $7.08 | — | SPONSORED ADS | 088786108 |
| NKTX | NKARTA INC | 3,150,732 | $6.648M | 1.1% | $2.00 | +9.0% | COM | 65487U108 |
| RGNX | REGENXBIO INC | 271,456 | $2.275M | 0.4% | $12.46 | -6.9% | COM | 75901B107 |